IVD契约製造市场规模：份额、成长分析、按产品类型、按技术、按服务类型、按地区 - 产业预测，2024-2031 年

2022年，IVD契约製造的全球市场规模为148亿美元，从2023年的165.2亿美元成长到2031年的397.4亿美元，在预测期内（2024-2031年）预计将以复合年增长率增长。 11.60%。

体外诊断药物（IVD）契约製造市场预计将显着成长，这主要是由于对个人化医疗（包括基因表现、生物标记发现和标靶治疗）日益关注的推动。随着医疗保健成本持续上升，尤其是在新兴市场，对标准化诊断解决方案的需求不断增加，推动了这一趋势。这项市场扩张的主要驱动力包括数位病理学、次世代定序和创新影像技术等诊断技术的进步，这些技术有助于开发更准确的诊断产品。 IVD 涵盖广泛的应用，从个人化妊娠测试到用于糖尿病管理的血糖值监测，从而增加了其市场吸引力。此外，製药业越来越依赖体外诊断药物，这些药物在最终用户中越来越受欢迎。人们对有助于及时检测、诊断和疾病预防的护理点监测设备也越来越感兴趣。随着高速诊断设备的客製化变得更加普遍，这种趋势预计将持续下去。此外，许多市场相关人员积极参与实施促进该产业成长的策略，进一步巩固了细分市场的发展轨迹。随着情况的发展，符合这些趋势的相关人员可能会在不断扩大的市场中抓住重要的商机。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• 客户和购买标准分析
• 市场吸引力指数
• 供应链分析
• 价格分析

按产品类型分類的 IVD契约製造市场规模

• 市场概况
• 消耗品
• 装置

IVD契约製造市场规模：依技术划分

• 市场概况
• 免疫检测
• 临床化学
• 分子诊断
• 血液学
• 微生物学
• 凝血和止血
• 其他技术

按服务类型分類的 IVD契约製造市场规模

• 市场概况
• 製造服务
• 检测开发
• 其他服务

IVD契约製造市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Jabil Inc.
• Sanmina Corporation
• TE Connectivity
• Celestica, Inc.
• West Pharmaceutical Services, Inc.
• Savyon Diagnostics, Ltd.
• KMC Systems
• Cenogenics Corporation
• Nova Biomedical
• Cone Bioproducts
• Kimball Electronics, Inc.
• Roche Diagnostics
• Viant Medical Holdings, Inc.
• Sysmex Corporation
• Stratec SE
• Thermo Fisher Scientific, Inc.
• Fujirebio
• Biokit（Werfen）
• Sekisui
• Prestige Diagnostics

结论和建议

Global IVD Contract Manufacturing Market size was valued at USD 14.80 billion in 2022 and is poised to grow from USD 16.52 billion in 2023 to USD 39.74 billion by 2031, growing at a CAGR of 11.60% during the forecast period (2024-2031).

The in vitro diagnostics (IVD) contract manufacturing market is poised for significant growth, largely fueled by the rising focus on personalized medicine, which encompasses gene expression, biomarker discovery, and targeted therapies. This trend is bolstered by the increasing demand for standardized diagnostic solutions as healthcare costs continue to escalate, particularly in emerging markets. Key drivers of this market expansion include advancements in diagnostic technologies such as digital pathology, next-generation sequencing, and innovative imaging techniques, which aid in the development of more accurate diagnostic products. IVDs encompass a diverse array of applications, from personalized pregnancy tests to blood glucose monitoring for diabetes management, thereby broadening their market appeal. Furthermore, the pharmaceutical industry's growing reliance on IVD devices amplifies their adoption among end users. There is also a notable surge in interest surrounding point-of-care monitoring devices, which facilitate timely testing, diagnosis, and disease prevention. This trend is expected to progress as customization in high-speed diagnostic devices becomes more prevalent. Additionally, numerous market players are actively engaged in executing strategies that enhance growth in this segment, further solidifying the IVD contract manufacturing market's trajectory. As the landscape evolves, stakeholders who align with these trends are likely to capture significant opportunities within the expanding market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ivd Contract Manufacturing Market Segmental Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region. By Product Type, the market is classified into Consumables, and Equipment. Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies. According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ivd Contract Manufacturing Market

The global IVD contract manufacturing market is primarily driven by the rising demand for advanced In Vitro Diagnostics (IVD) devices, fueled by the increasing prevalence of chronic illnesses, including diabetes, cancer, and heart disease. This escalating need has prompted manufacturers to enhance their productivity to tackle pressing global health challenges effectively. Additionally, contract manufacturers are pivotal in delivering cost-efficient and high-quality solutions, empowering IVD companies to comply with stringent regulatory requirements. As a result, the contract manufacturing sector is positioned to play an essential role in the healthcare ecosystem, supporting innovation and access to critical diagnostic tools worldwide.

Restraints in the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market encounters significant constraints primarily due to elevated development and manufacturing costs. Producing IVD devices demands substantial financial commitments for research, regulatory compliance, and state-of-the-art manufacturing facilities. These high expenses associated with creating innovative diagnostic technologies often deter small to medium-sized enterprises from entering the industry, thereby hindering overall market growth. The financial burden can limit the capacity of these companies to invest in necessary advancements and expertise, which could otherwise enhance their competitiveness and ability to innovate within the IVD landscape. Consequently, the market's expansion is restricted by these financial barriers.

Market Trends of the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market is increasingly witnessing a trend towards outsourcing production to emerging markets, notably in the Asia-Pacific region. This shift is driven by the allure of reduced labor costs, the availability of a skilled workforce, and the imperative to manage rising manufacturing pressures. Companies are capitalizing on these advantages to enhance operational efficiency while accessing new growth opportunities in expanding markets. This trend not only allows manufacturers to significantly lower expenses but also positions them to cater to the increasing demand for in vitro diagnostics in these dynamic regions, ultimately reshaping the industry's competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• Market Attractiveness Index
• Supply Chain Analysis
• Pricing Analysis

Global IVD Contract Manufacturing Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Consumables
• Equipment

Global IVD Contract Manufacturing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Immunoassays
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation & Hemostasis
• Other Technologies

Global IVD Contract Manufacturing Market Size by Service Type & CAGR (2024-2031)

• Market Overview
• Manufacturing Services
• Assay Development
• Other Services

Global IVD Contract Manufacturing Market Size & CAGR (2024-2031)

• North America, (Product Type, Technology, Service Type)
  • US
  • Canada
• Europe, (Product Type, Technology, Service Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product Type, Technology, Service Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product Type, Technology, Service Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product Type, Technology, Service Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Jabil Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanmina Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TE Connectivity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celestica, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Savyon Diagnostics, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KMC Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cenogenics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cone Bioproducts
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kimball Electronics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stratec SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biokit (Werfen)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation